Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes

被引:22
|
作者
Vu, Dinh H. [1 ]
Nguyen, Duy A. [1 ]
Delattre, Isabelle K. [2 ]
Ho, Trong T. [1 ]
Do, Hong G. [3 ]
Pham, Hong N. [4 ]
Dao, Xuan C. [5 ]
Tran, Nhan T. [3 ]
Nguyen, Gia B. [5 ]
Van Bambeke, Francoise [2 ]
Tulkens, Paul M. [2 ]
Nguyen, Hoang A. [1 ]
机构
[1] Hanoi Univ Pharm, Natl Drug Informat & Adverse Drug React Monitorin, 13-15 Le Thanh Tong, Hanoi, Vietnam
[2] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium
[3] Bach Mai Hosp, Dept Pharm, Hanoi, Vietnam
[4] Bach Mai Hosp, Dept Microbiol, Hanoi, Vietnam
[5] Bach Mai Hosp, Intens Care Unit, Hanoi, Vietnam
关键词
Vancomycin; Continuous infusion; Loading dose; Maintenance dose; Critically ill; AUGMENTED RENAL CLEARANCE; INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-AUREUS; INTERMITTENT INFUSION; PHARMACODYNAMICS; INFECTIONS; SIZE;
D O I
10.1016/j.ijantimicag.2019.09.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Despite extensive clinical use, limited data are available on optimal loading and maintenance doses of vancomycin in critically ill patients. This study aimed to develop a rational approach for optimised dosage of vancomycin given in a continuous infusion in critically ill patients. Methods: Vancomycin pharmacokinetic (PK) data (total serum concentrations) were obtained from 55 intensive care unit (ICU) patients (Bach Mai Hospital, Hanoi, Vietnam) receiving a 20 mg/kg loading dose followed by continuous infusion stratified by creatinine clearance (CLCr). Population PK modelling and Monte Carlo simulations were performed using a nonlinear mixed-effects modelling (NONMEM) program for a target of 20-30 mg/L to optimise efficacy and minimise nephrotoxicity. Results: A two-compartment model with first-order elimination best fitted the PK data with central and peripheral volumes of distribution of 1.01 and 2.39 L/kg, respectively (allometric scaling to a 70 kg standard subject). The population total clearance of 3.63 L/h was only explained by renal function in the covariate and final model. The simulations showed that a 25-mg/kg loading dose infused over 90 minutes was optimal to reach the target range. The optimal maintenance dose for low renal function (CLCr < 45 mL/min) was 1000-1500 mg/day. For augmented renal clearance (CLCr > 130 mL/min) the dose should be up to 3500 mg/day or even 4500 mg/day to achieve adequate exposure. These simulated maintenance doses were larger than previously proposed for non-ICU patients. Conclusion: Large loading and maintenance doses of vancomycin are generally needed in critically ill patients. Because of high interindividual variability in vancomycin PK, drug monitoring may still be necessary. (C) 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:702 / 708
页数:7
相关论文
共 39 条
  • [31] Population Pharmacokinetics of Prolonged Infusion for Meropenem: Tailoring Dosing Recommendations for Chinese Critically Ill Patients on Continuous Renal Replacement Therapy with Consideration for Renal Function
    Peng, Yaru
    Liu, Yalan
    Cheng, Zeneng
    Zhang, Qiang
    Xie, Feifan
    Zhu, Sucui
    Li, Sanwang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1105 - 1117
  • [32] Levetiracetam dosing in continuous renal replacement therapy: A systematic review and development of a novel pharmacokinetic model to optimise dosing in critically ill patients. Do recommended doses achieve therapeutic drug concentrations?
    Sweatman, James
    Al-Mahdi, Sarraa
    Lonsdale, Dagan O.
    Leaver, Susannah
    Rhodes, Andrew
    JOURNAL OF THE INTENSIVE CARE SOCIETY, 2025,
  • [33] A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis (vol 43, pg 747, 2021)
    Garbez, N.
    Mbatchi, L. C.
    Maseda, E.
    THERAPEUTIC DRUG MONITORING, 2022, 44 (02) : 357 - 357
  • [34] Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients
    Swart, EL
    Zuideveld, KP
    de Jongh, J
    Danhof, M
    Thijs, LG
    van Schijndel, RMJS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) : 185 - 194
  • [35] Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients
    Eleonora L. Swart
    Klaas P. Zuideveld
    Joost de Jongh
    Meindert Danhof
    Lambertus G. Thijs
    Robert M. J. Strack van Schijndel
    European Journal of Clinical Pharmacology, 2006, 62 : 185 - 194
  • [36] Population Pharmacokinetics of Fluconazole in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration: Using Monte Carlo Simulations To Predict Doses for Specified Pharmacodynamic Targets
    Patel, Kashyap
    Roberts, Jason A.
    Lipman, Jeffrey
    Tett, Susan E.
    Deldot, Megan E.
    Kirkpatrick, Carl M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) : 5868 - 5873
  • [37] Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion
    Carrie, Cedric
    Legeron, Rachel
    Petit, Laurent
    Ollivier, Julien
    Cottenceau, Vincent
    d'Houdain, Nicolas
    Boyer, Philippe
    Lafitte, Melanie
    Xuereb, Fabien
    Sztark, Francois
    Breilh, Dominique
    Biais, Matthieu
    JOURNAL OF CRITICAL CARE, 2018, 48 : 66 - 71
  • [38] Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
    Cojutti, Pier Giorgio
    Gatti, Milo
    Rinaldi, Matteo
    Tonetti, Tommaso
    Laici, Cristiana
    Mega, Chiara
    Siniscalchi, Antonio
    Giannella, Maddalena
    Viale, Pierluigi
    Pea, Federico
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [39] An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48-producing Enterobacterales and preventing resistance development in critically ill patients
    Cojutti, Pier Giorgio
    Pai, Manjunath P.
    Gatti, Milo
    Rinaldi, Matteo
    Ambretti, Simone
    Viale, Pierluigi
    Pea, Federico
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024,